Ophthalmologic Manifestations of Herpes Simplex Keratitis Clinical Presentation
- Author: Jim C Wang, MD; Chief Editor: Hampton Roy Sr, MD more...
History
- Patients with HSV keratitis may complain of the following:
- Pain
- Photophobia
- Blurred vision
- Tearing
- Redness
- A history of prior episodes in patients with recurrent disease may exist. Among patients with ocular HSV, those with previous stromal involvement have a significantly higher risk of subsequent stromal keratitis; in contrast, patients with epithelial keratitis alone have no increased rate of recurrent HSV disease.
Physical
HSV keratitis may be divided into 4 categories: infectious epithelial keratitis, neurotrophic keratopathy, stromal keratitis, and endotheliitis.
- Infectious epithelial keratitis is characterized by corneal vesicles, dendritic ulcers, and geographic ulcers.
- The earliest sign of active viral replication in the corneal epithelium is small, raised, clear vesicles that are analogous to the vesicular eruptions seen in mucocutaneous herpes infection elsewhere in the body. These infectious epithelial vesicles are rarely seen or recognized during a patient's first presentation. However, in patients with a known history of HSV keratitis, infectious epithelial vesicles may be observed even in the absence of any clinical symptoms.
- Within several hours, these corneal vesicles coalesce into a dendritic pattern. In some patients, particularly patients who are immunocompromised, the recurring infection may be arrested at the vesicle stage. As the disease progresses, a central epithelial defect develops. The resultant dendritic ulcer is the most common presentation of HSV keratitis.
- Prominent features of a HSV dendritic ulcer include branching terminal bulbs, swollen epithelial borders that contain live viruses, and central ulceration through the basement membrane.
- If the infectious ulcer enlarges, its shape is no longer linear. It is then referred to as a geographic ulcer. The swollen epithelial cells and the scalloped or geographic borders differentiate this infectious lesion from the smooth borders of a neurotrophic ulcer.
Herpes simplex virus geographic ulcer.
- Neurotrophic keratopathy develops in patients with previous HSV epithelial disease. Traditionally thought of as neither infectious nor immunologic in origin, neurotrophic keratopathy arises from impaired corneal innervation and decreased tear formation, exacerbated by long-term use of topical medications, especially antiviral agents. However, evidence suggests that HSV replication may occur in persistent epithelial defects.
- The earliest signs of neurotrophic keratopathy include an irregular corneal surface and punctate epithelial erosions. These erosions may progress to a persistent epithelial defect and eventual stromal ulceration.
- In contrast to the irregular shape and scalloped borders of an infectious geographic ulcer, a neurotrophic ulcer is typically oval with smooth borders and often lies within the interpalpebral fissures, located in the central or inferior paracentral area of the cornea. Decreased corneal sensitivity helps confirm the diagnosis.
- Complications of neurotrophic keratopathy include stromal scarring, neovascularization, necrosis, and perforation.
Large neurotrophic ulcer.
- Corneal stromal inflammation may be the primary manifestation of HSV keratitis or may be seen secondary to infectious epithelial keratitis, neurotrophic keratopathy, or endotheliitis.[6] The 2 forms of primary stromal involvement are necrotizing stromal keratitis and ISK.
- Necrotizing stromal keratitis, characterized by dense stromal infiltrate, ulceration, and necrosis, is believed to result from viral replication in stromal keratocytes and severe host inflammatory response. This destructive intrastromal inflammation may lead to thinning and perforation within a short period. The use of topical corticosteroids without antiviral coverage may be a possible risk factor for its development.
- ISK is a common manifestation of chronic recurrent ocular HSV disease. An antibody-complement cascade to retained viral antigen within the stroma is believed to be the underlying mechanism. ISK may present clinically with focal, multifocal, or diffuse cellular infiltrates; immune rings; neovascularization; or ghost vessels at any level of the cornea.
- Significant anterior chamber inflammation may accompany stromal keratitis.
- Permanent stromal scarring may lead to profound visual loss. In addition, all stromal keratitis types may develop uveitis, trabeculitis, and secondary glaucoma.
Inactive immune stromal keratitis.
- Endotheliitis
- Clinical signs of endotheliitis include keratic precipitates (KP), overlying stromal and epithelial edema, and absence of stroma infiltrate or neovascularization. A mild-to-moderate iritis is frequently seen.
- Immunologic reaction to viral antigens within corneal endothelial cells has been proposed as the underlying pathogenesis; however, active viral replication may also play a role. The inflammation directed at the endothelium may cause endothelial decompensation and overlying stromal and epithelial edema.
- HSV endotheliitis can be classified as disciform, diffuse, or linear. Disciform endotheliitis presents with a round area of corneal edema in a central or paracentral region with a clear demarcation between involved and uninvolved cornea. Diffuse endotheliitis shows scattered KP and may stem from a previous disciform area of involvement. Linear endotheliitis appears as a line of KP progressing centrally from the limbus, with peripheral corneal edema trailing the migrating line of KP. The line of KP can be sectoral or circumferential; it may take on either a straight pattern or a more serpiginous pattern.
Disciform endotheliitis with secondary stromal ulceration.
Causes
- Infectious epithelial keratitis results from active viral replication within the corneal epithelium.
- Neurotrophic keratopathy is poorly understood. The cause is thought to be multifactorial and includes decreased corneal innervation and tear secretion (as a result of prior HSV infection of the sensory nerves), toxicity from topical agents, and underlying stromal inflammation. Evidence suggests that active HSV reproduction may also play a role.
- Necrotizing stromal keratitis arises from direct infection of the corneal stroma and the resultant severe host inflammatory response.
- ISK is an antibody-complement cascade triggered by retained viral antigen or altered host antigen within the stroma.
- Endotheliitis is believed to be primarily an immunologic reaction to an antigen in endothelial cells; however, the role of live virus has been speculated.
Kaye S, Choudhary A. Herpes simplex keratitis. Prog Retin Eye Res. Jul 2006;25(4):355-80. [Medline].
Jain V, Pineda R. Reactivated herpetic keratitis following laser in situ keratomileusis. J Cataract Refract Surg. May 2009;35(5):946-8. [Medline].
Khalili MR, Mehdizadeh M, Mehryar M. Herpetic epithelial keratitis after intravitreal injection of bevacizumab (avastin). Cornea. Apr 2009;28(3):360-1. [Medline].
Patel NN, Teng CC, Sperber LT, Dodick JM. New-onset herpes simplex virus keratitis after cataract surgery. Cornea. Jan 2009;28(1):108-10. [Medline].
Hsiao CH, Yeung L, Yeh LK, et al. Pediatric herpes simplex virus keratitis. Cornea. Apr 2009;28(3):249-53. [Medline].
Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review. Surv Ophthalmol. Mar-Apr 2009;54(2):226-34. [Medline].
Guess S, Stone DU, Chodosh J. Evidence-based treatment of herpes simplex virus keratitis: a systematic review. Ocul Surf. Jul 2007;5(3):240-50. [Medline].
Miserocchi E, Modorati G, Galli L, Rama P. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Am J Ophthalmol. Oct 2007;144(4):547-51. [Medline].
Spelsberg H, Reichelt JA. [Amniotic membrane transplantation in proven ulcerative herpetic keratitis: successful anti-inflammatory treatment in time]. Klin Monatsbl Augenheilkd. Jan 2008;225(1):75-9. [Medline].
Garcia DD, Farjo Q, Musch DC, Sugar A. Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea. Sep 2007;26(8):930-4. [Medline].
van Lint AL, Torres-Lopez E, Knipe DM. Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease. Virology. Nov 25 2007;368(2):227-31. [Medline].
Pepose JS, Keadle TL, Morrison LA. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Am J Ophthalmol. Mar 2006;141(3):547-557. [Medline].
de Rojas Silva V, Rodriguez-Conde R, Cobo-Soriano R, Beltran J, Llovet F, Baviera J. Laser in situ keratomileusis in patients with a history of ocular herpes. J Cataract Refract Surg. Nov 2007;33(11):1855-9. [Medline].
Shtein RM, Stahl RM, Saxe SJ, Mian SI. Herpes simplex keratitis after intravitreal triamcinolone acetonide. Cornea. Jun 2007;26(5):641-2. [Medline].
Chong EM, Wilhelmus KR, Matoba AY, Jones DB, Coats DK, Paysse EA. Herpes simplex virus keratitis in children. Am J Ophthalmol. Sep 2004;138(3):474-5. [Medline].
Ekatomatis P. Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma. Br J Ophthalmol. Aug 2001;85(8):1008-9. [Medline].
Gaynor BD, Margolis TP, Cunningham ET Jr. Advances in diagnosis and management of herpetic uveitis. Int Ophthalmol Clin. Spring 2000;40(2):85-109. [Medline].
Herpetic Eye Disease Study Group. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group. Arch Ophthalmol. Aug 2000;118(8):1030-6. [Medline].
Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med. Jul 30 1998;339(5):300-6. [Medline].
Herpetic Eye Disease Study Group. Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group. Cornea. Mar 2001;20(2):123-8. [Medline].
Holland EJ, Schwartz GS. Classification of herpes simplex virus keratitis. Cornea. Mar 1999;18(2):144-54. [Medline].
Kaufman HE, Varnell ED, Thompson HW. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Arch Ophthalmol. Jun 1998;116(6):777-80. [Medline].
Liesegang TJ. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea. Mar 1999;18(2):127-43. [Medline].
Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. Jan 2001;20(1):1-13. [Medline].
Nesburn AB, Burke RL, Ghiasi H, Slanina SM, Wechsler SL. A therapeutic vaccine that reduces recurrent herpes simplex virus type 1 corneal disease. Invest Ophthalmol Vis Sci. Jun 1998;39(7):1163-70. [Medline].
Remeijer L, Maertzdorf J, Doornenbal P, Verjans GM, Osterhaus AD. Herpes simplex virus 1 transmission through corneal transplantation. Lancet. Feb 10 2001;357(9254):442. [Medline].
Rezende RA, Uchoa UB, Raber IM, Rapuano CJ, Laibson PR, Cohen EJ. New onset of herpes simplex virus epithelial keratitis after penetrating keratoplasty. Am J Ophthalmol. Mar 2004;137(3):415-9. [Medline].
Romanowski EG, Bartels SP, Gordon YJ. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model. Invest Ophthalmol Vis Sci. Feb 1999;40(2):378-84. [Medline].
Tambasco FP, Cohen EJ, Nguyen LH, Rapuano CJ, Laibson PR. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol. Apr 1999;117(4):445-9. [Medline].

